Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL

13 Aug 2024

Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL

Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilities of Rs 2,475.43 crore of the company as under:

Long term rating - CRISIL AA-/ Stable
Short term rating - CRISIL A1+

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions